Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C
AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some report...
Gespeichert in:
| Veröffentlicht in: | Bratislavské lékarské listy 2007, Vol.108 (2), p.65-69 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 69 |
|---|---|
| container_issue | 2 |
| container_start_page | 65 |
| container_title | Bratislavské lékarské listy |
| container_volume | 108 |
| creator | Biyikoglu, Ibrahim Filik, Levent Oguz, Dilek Cicek, Bahattin Yilmaz, Birhan Altiparmak, Emin |
| description | AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature (Tab. 6, Ref. 39) Full Text (Free, PDF) www.bmj.sk. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68141278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68141278</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-43e17d7b007f4118f6d1408abf06cd88fa6eefe84adcaa63e065e33d90c63a873</originalsourceid><addsrcrecordid>eNpNkEFLAzEQhXNQbK3-BZmT6GExadJserRFbaHgRc9LNjuhkW6yJtlKf4T_2S1W8DQzj--9B3NGxpRSWcynQo3IZUoflAo-Y_KCjFgp1Ww4x-R73XbaZAgWttjp7LJLsAATIoL22dWhOcDdcYPVwtxDwhi6kAZs7_IBggfnM0Y7yP4hulrvXXQeckSdW_QZIqYu-IQDB8f8QUvw5fIWzHbwOPOvd3lFzq3eJbw-zQl5f356W66KzevLevm4KTo2FbkQHFnZlDWlpRWMKSsbJqjStaXSNEpZLREtKqEbo7XkSOUMOW_m1EiuVckn5PY3t4vhs8eUq9Ylg7ud9hj6VEnFBJuWagBvTmBft9hUXXStjofq74H8B4Jkbxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68141278</pqid></control><display><type>article</type><title>Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Biyikoglu, Ibrahim ; Filik, Levent ; Oguz, Dilek ; Cicek, Bahattin ; Yilmaz, Birhan ; Altiparmak, Emin</creator><creatorcontrib>Biyikoglu, Ibrahim ; Filik, Levent ; Oguz, Dilek ; Cicek, Bahattin ; Yilmaz, Birhan ; Altiparmak, Emin</creatorcontrib><description>AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature (Tab. 6, Ref. 39) Full Text (Free, PDF) www.bmj.sk.</description><identifier>ISSN: 0006-9248</identifier><identifier>PMID: 17685004</identifier><language>eng</language><publisher>Slovakia</publisher><subject>Antiviral Agents - administration & dosage ; Drug Therapy, Combination ; Female ; Hepatitis B Antibodies - blood ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - immunology ; Humans ; Interferon-alpha - administration & dosage ; Male ; Middle Aged ; Recombinant Proteins ; Ribavirin - administration & dosage</subject><ispartof>Bratislavské lékarské listy, 2007, Vol.108 (2), p.65-69</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17685004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biyikoglu, Ibrahim</creatorcontrib><creatorcontrib>Filik, Levent</creatorcontrib><creatorcontrib>Oguz, Dilek</creatorcontrib><creatorcontrib>Cicek, Bahattin</creatorcontrib><creatorcontrib>Yilmaz, Birhan</creatorcontrib><creatorcontrib>Altiparmak, Emin</creatorcontrib><title>Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C</title><title>Bratislavské lékarské listy</title><addtitle>Bratisl Lek Listy</addtitle><description>AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature (Tab. 6, Ref. 39) Full Text (Free, PDF) www.bmj.sk.</description><subject>Antiviral Agents - administration & dosage</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Hepatitis B Antibodies - blood</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Humans</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Recombinant Proteins</subject><subject>Ribavirin - administration & dosage</subject><issn>0006-9248</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEFLAzEQhXNQbK3-BZmT6GExadJserRFbaHgRc9LNjuhkW6yJtlKf4T_2S1W8DQzj--9B3NGxpRSWcynQo3IZUoflAo-Y_KCjFgp1Ww4x-R73XbaZAgWttjp7LJLsAATIoL22dWhOcDdcYPVwtxDwhi6kAZs7_IBggfnM0Y7yP4hulrvXXQeckSdW_QZIqYu-IQDB8f8QUvw5fIWzHbwOPOvd3lFzq3eJbw-zQl5f356W66KzevLevm4KTo2FbkQHFnZlDWlpRWMKSsbJqjStaXSNEpZLREtKqEbo7XkSOUMOW_m1EiuVckn5PY3t4vhs8eUq9Ylg7ud9hj6VEnFBJuWagBvTmBft9hUXXStjofq74H8B4Jkbxg</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Biyikoglu, Ibrahim</creator><creator>Filik, Levent</creator><creator>Oguz, Dilek</creator><creator>Cicek, Bahattin</creator><creator>Yilmaz, Birhan</creator><creator>Altiparmak, Emin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2007</creationdate><title>Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C</title><author>Biyikoglu, Ibrahim ; Filik, Levent ; Oguz, Dilek ; Cicek, Bahattin ; Yilmaz, Birhan ; Altiparmak, Emin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-43e17d7b007f4118f6d1408abf06cd88fa6eefe84adcaa63e065e33d90c63a873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antiviral Agents - administration & dosage</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Hepatitis B Antibodies - blood</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Humans</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Recombinant Proteins</topic><topic>Ribavirin - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biyikoglu, Ibrahim</creatorcontrib><creatorcontrib>Filik, Levent</creatorcontrib><creatorcontrib>Oguz, Dilek</creatorcontrib><creatorcontrib>Cicek, Bahattin</creatorcontrib><creatorcontrib>Yilmaz, Birhan</creatorcontrib><creatorcontrib>Altiparmak, Emin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bratislavské lékarské listy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biyikoglu, Ibrahim</au><au>Filik, Levent</au><au>Oguz, Dilek</au><au>Cicek, Bahattin</au><au>Yilmaz, Birhan</au><au>Altiparmak, Emin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C</atitle><jtitle>Bratislavské lékarské listy</jtitle><addtitle>Bratisl Lek Listy</addtitle><date>2007</date><risdate>2007</risdate><volume>108</volume><issue>2</issue><spage>65</spage><epage>69</epage><pages>65-69</pages><issn>0006-9248</issn><abstract>AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature (Tab. 6, Ref. 39) Full Text (Free, PDF) www.bmj.sk.</abstract><cop>Slovakia</cop><pmid>17685004</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-9248 |
| ispartof | Bratislavské lékarské listy, 2007, Vol.108 (2), p.65-69 |
| issn | 0006-9248 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68141278 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Antiviral Agents - administration & dosage Drug Therapy, Combination Female Hepatitis B Antibodies - blood Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - immunology Humans Interferon-alpha - administration & dosage Male Middle Aged Recombinant Proteins Ribavirin - administration & dosage |
| title | Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/ribavirin treatment response in patients with chronic hepatitis C |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T02%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20hepatitis%20B%20core%20antibody%20(anti%20HBc)%20seropositivity%20on%20interferon/ribavirin%20treatment%20response%20in%20patients%20with%20chronic%20hepatitis%20C&rft.jtitle=Bratislavsk%C3%A9%20l%C3%A9karsk%C3%A9%20listy&rft.au=Biyikoglu,%20Ibrahim&rft.date=2007&rft.volume=108&rft.issue=2&rft.spage=65&rft.epage=69&rft.pages=65-69&rft.issn=0006-9248&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E68141278%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68141278&rft_id=info:pmid/17685004&rfr_iscdi=true |